PO.TB10.10 · 肿瘤生物学

绘制淋巴样反应对肿瘤生长和淋巴结转移的图谱:胰腺导管腺癌的多组学空间分析揭示三级淋巴结构

Mapping lymphoid responses to tumor growth and lymph node metastasis: multiomic spatial analysis of pancreatic ductal adenocarcinoma reveals tertiary lymph node structures

海报缩略图:绘制淋巴样反应对肿瘤生长和淋巴结转移的图谱:胰腺导管腺癌的多组学空间分析揭示三级淋巴结构
编号 2222 展板 8 时间 4/20 09:00–12:00 区域 Section 31 主讲 James Agolia, BA;MD
分会场 Tertiary Lymphoid Structures in Cancer
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

James P. Agolia1, Chuner Guo1, Rosyli F. Reveron-Thornton1, Xiaomo Li2, Maria Moozhiyil Korah1, Angela Tabora1, Byrne Lee1, Amanda R. Kirane1, George Poultsides1, Brendan Visser1, Gregory W. Charville2, Michael T. Longaker1, Deshka S. Foster1, Daniel Delitto1

1Surgery, Stanford University, Stanford, CA,2Pathology, Stanford University, Stanford, CA

摘要 Abstract

中文摘要
引言:在未来五年内,胰腺导管腺癌(PDAC)将成为美国癌症死亡的第二大病因;即使接受手术切除和化疗,中位总生存期仍不足三年。空间转录组学和蛋白质组学分析是发现PDAC治疗靶点的途径之一。既往空间转录组学研究已揭示原发和转移样本中显著的瘤内异质性,但大多数缺乏亚细胞分辨率和多组学尺度。 方法:我们使用Singular G4X平台,对来自8例患者的福尔马林固定石蜡包埋的配对原发肿瘤和转移淋巴结中的31个感兴趣区域进行了空间多组学分析。所有患者均经病理诊断为PDAC,并在同一癌症中心接受了新辅助化疗,8例中有7例显示出病理治疗反应,对治疗呈部分缓解。数据使用python进行分析。 结果:经质量控制后,共整合了240万个细胞。主要细胞类型经人工注释:腺泡细胞(CPB1+ GATM+)、脂肪细胞(ADIPOQ+ PLIN1+)、B细胞(MS4A1+ HLA-DRA+)、癌相关成纤维细胞(COL1A1+ LUM+)、浆细胞(JCHAIN+ IGHA1/IGHM+)、巨噬细胞(CD163+ CD68+)、肥大细胞(KIT+)、神经内分泌细胞(NRXN1+ NCAM1+)、周细胞/内皮细胞(PECAM1+ RGS5+)、平滑肌细胞(TAGLN+ MYH11+)和T细胞(CD3D+ IL7R+)。肿瘤细胞形成三个截然不同的簇:KRT19+ MUC1+导管细胞、PIGR+ GATM+导管细胞,以及STAT1+ CD44+细胞(来自一例肉瘤样去分化患者)。肿瘤微环境中占主导地位的细胞类型——癌相关成纤维细胞(CAFs)可进一步分为炎性CAF(CXCL12高/IL6高)、机械反应性CAF(PDGFRB高/ACTA2高)和稳态CAF表型。尽管我们在选取感兴趣区域时并未明确考虑三级淋巴样结构(TLSs),但我们发现8例中有7例、19个肿瘤切片中有9个含有推定的TLSs,其中4个切片含有一个以上的TLS区域。TLS形态与肿瘤阳性淋巴结中淋巴样聚集体的形态相似。在受累淋巴结中同样观察到CAFs占主导。TLSs内的B细胞CD20蛋白染色阳性并表达CXCR5转录本;它们被CD3及CD4/CD8蛋白染色阳性的T细胞所包围。CXCR5与其结合配体CXCL13(一种已知的TLS形成触发因子)紧密共定位。 结论:在一组伴淋巴结转移的PDAC患者队列中,多组学空间分析在几乎所有患者中均揭示了TLSs,提示PDAC间质内存在免疫潜能。CXCR5-CXCL13轴应继续作为TLS形成研究的重点靶标。
查看英文原文 English abstract
Introduction : Within the next five years, pancreatic ductal adenocarcinoma (PDAC) will become the second-highest cause of cancer death in the United States; even with surgical resection and chemotherapy, median overall survival remains less than three years. Spatial transcriptomic and proteomic analysis is one pathway toward therapeutic target discovery for PDAC. While previous spatial transcriptomic studies have uncovered remarkable intratumoral heterogeneity in primary and metastatic samples, most lack subcellular resolution and multiomic scale. Methods : Using the Singular G4X platform, we performed spatial multiomic analysis of 31 regions of interest in formalin-fixed, paraffin-embedded matched primary tumor and metastatic lymph nodes from eight patients. All patients had a pathological diagnosis of PDAC and received neoadjuvant chemotherapy at a single cancer center, and 7/8 patients showed pathological treatment effect with partial response to therapy. Data were analyzed in python. Results : After quality control, 2.4 million cells were integrated. Major cell types were manually annotated: acinar cells ( CPB1 + GATM +), adipocytes ( ADIPOQ + PLIN1 +), B cells ( MS4A1 + HLA-DRA +), cancer-associated fibroblasts ( COL1A1 + LUM +), plasma cells ( JCHAIN + IGHA1 / IGHM +), macrophages ( CD163 + CD68 +), mast cells ( KIT +), neuroendocrine cells ( NRXN1 + NCAM1 +), pericytes/endothelial cells ( PECAM1 + RGS5 +), smooth muscle cells ( TAGLN + MYH11 +), and T cells ( CD3D + IL7R +). Tumor cells formed three distinct clusters: KRT19 + MUC1 + ductal cells, PIGR + GATM + ductal cells, and STAT1 + CD44 + cells (from one patient with sarcomatoid dedifferentiation). The predominant cell type in the tumor microenvironment, cancer-associated fibroblasts (CAFs) could be subclustered into inflammatory CAF ( CXCL12 -high IL6 -high), mechanoresponsive CAF ( PDGFRB -high ACTA2 -high), and steady-state CAF phenotypes. Although we did not select regions of interest explicitly with tertiary lymphoid structures (TLSs) in mind, we found that 7/8 patients and 9/19 tumor sections contained putative TLSs, with 4 sections containing more than one TLS area. TLS morphology appeared similar to that of lymphoid aggregates in tumor-positive lymph nodes. A predominance of CAFs was also noted in the involved lymph nodes. B cells within TLSs stained positive for CD20 protein and expressed CXCR5 transcripts; they were surrounded by T cells that stained positive for CD3 and CD4/CD8 proteins. CXCR5 colocalized closely with its binding partner CXCL13, a known trigger of TLS formation. Conclusion : In a cohort of PDAC patients with lymph node metastasis, multiomic spatial analysis revealed TLSs in nearly all patients, suggestive of immune potential within the PDAC stroma. The CXCR5-CXCL13 axis should remain a target of active investigation in TLS formation.
利益披露 Disclosure
J. P. Agolia, None.. C. Guo, None.. R. F. Reveron-Thornton, None.. X. Li, None.. M. M. Korah, None.. A. Tabora, None.. B. Lee, None.. A. R. Kirane, None.. G. Poultsides, None.. B. Visser, None.. G. W. Charville, None.. M. T. Longaker, None.. D. S. Foster, None.. D. Delitto, None.

← 返回 AACR 2026 检索